JPMORGAN CHASE & CO (JPM)
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Financials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for JPM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JPM | Director; Retired Chairman and Chief Executive Officer of Johnson & Johnson | 65 | ["Retired Chairman and Chief Executive Officer of Johnson & Johnson","Deep understanding of financial reporting standards","Expertise in overseeing innovative technologies","Seasoned executive experience operating in diverse geographic, political and regulatory environments","Broad governance expertise through public company board service"] | ["Audit","Corporate Governance & Nominating","Audit Committee","Corporate Governance & Nominating Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AAPL | Former Chair and CEO, Johnson & Johnson; Director | 65 | ["executive leadership experience", "brand marketing expertise", "experience in health and technology"] | ["Nominating Committee", "People and Compensation Committee"] | 2026 |
| IBM | Former Chairman and Chief Executive Officer; Lead Director | 65 | ["Former Chairman and Chief Executive Officer, Johnson & Johnson","Extensive global business experience and knowledge of financial and strategic issues and risk management as former executive chairman and chief executive officer of Johnson & Johnson","Deep understanding of complex operational issues facing multinational companies, including technology evolution and research and development","Public policy expertise as former Chair of the Business Roundtable’s Corporate Governance Committee and former member of the Business Council Executive Committee","active participation in the strategic planning of the Board agendas and meetings","authority to call meetings of the independent directors","liaison between the Chairman and the independent directors","reviews and approves meeting schedules","ensures availability for consultation with major stockholders","presides at all meetings of the Board when the Chairman is not present","conducts one-on-one debriefs with the Chairman after meetings","spends time with senior management to understand business and strategy","analyzes CEO performance","maintains regular contact with Board members","leads the Board self-evaluation process","attends all Board committee meetings"] | ["Audit","Executive"] | 2026 |
| JNJ | Executive Chairman, Board of Directors; Executive Chairman of the Board | 61 | ["Leadership of global business in healthcare industry","Expertise in strategy and operations of our Company as well as its risks and challenges","Deep commitment to ethical, Credo-based leadership"] | ["Finance"] | 2022 |
Biography sourced from the proxy statement filing.
Retired Chairman and Chief Executive Officer of Johnson & Johnson
Qualification Highlights
Finance and Accounting: Deep understanding of financial reporting standards and oversight of enterprise financial condition from experience as CEO of Johnson & Johnson
Technology: Expertise in overseeing innovative technologies, AI, information security and privacy issues through executive and board positions
International Business Operations: Seasoned executive experience operating in diverse geographic, political and regulatory environments
Public Company Governance: Broad governance expertise through public company board service and as former Chair of the Business Roundtable s Corporate Governance Committee
Career Highlights
Johnson & Johnson, a global healthcare company
Executive Chairman (2022)
Chairman, Chief Executive Officer, Chairman of the Executive Committee (2012-2021)
Worldwide Chairman of the Surgical Care Group and the Medical Devices and Diagnostics Group and member of the Executive Committee (2009)
Company Group Chairman, Ethicon (2008-2009)
Novartis Pharmaceuticals Corporation, a multinational medicines company
Head of North America pharmaceutical business (2004-2008)
Education
Graduate of the U.S. Military Academy at West Point
M.B.A., The Wharton School of the University of Pennsylvania
Other U.S.-Listed Public Company Directorships Within the Past Five Years
Apple Inc. (since 2021)
IBM (since 2014)
Johnson & Johnson (2012-2022)
Other Experience
Managing Director, ICONIQ Capital, LLC
Board Member, Neurotech Pharmaceuticals, Inc.
Board Member, Xiara Therapeutics, Inc.
Board Member, Travis Manion Foundation
Board Member, Wharton Board of Overseers
Board Member, Cleveland Clinic
Former Member and Chair of the Corporate Governance Committee, Business Roundtable
Age: 65
Director since: 2022
Committees: Audit Committee, Corporate Governance & Nominating Committee